Related references
Note: Only part of the references are listed.Implications of metabolism-driven myeloid dysfunctions in cancer therapy
Laura Strauss et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
Ke Xu et al.
SCIENCE (2021)
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
Yimei Feng et al.
FRONTIERS IN ONCOLOGY (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer
Thomas Rogers et al.
TRENDS IN CANCER (2021)
Heterogeneous subsets of B-lineage regulatory cells (Breg cells)
Yoshihiro Baba et al.
INTERNATIONAL IMMUNOLOGY (2020)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
mTORC1 coordinates an immediate unfolded protein response-related transcriptome in activated B cells preceding antibody secretion
Brian T. Gaudette et al.
NATURE COMMUNICATIONS (2020)
Reverting Immune Suppression to Enhance Cancer Immunotherapy
Bella S. Guerrouahen et al.
FRONTIERS IN ONCOLOGY (2020)
Signaling networks in immunometabolism
Jordy Saravia et al.
CELL RESEARCH (2020)
mTOR signaling at the crossroads of environmental signals and T-cell fate decisions
Hongling Huang et al.
IMMUNOLOGICAL REVIEWS (2020)
Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
Mee-Sup Yoon
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
Henry Kurniawan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
TGF-β suppresses type 2 immunity to cancer
Ming Liu et al.
NATURE (2020)
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Haojie Jin et al.
ELIFE (2020)
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Simone Nussing et al.
FRONTIERS IN IMMUNOLOGY (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat
Yang Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Metabolism of immune cells in cancer
Robert D. Leone et al.
NATURE REVIEWS CANCER (2020)
B cell memory: building two walls of protection against pathogens
Munir Akkaya et al.
NATURE REVIEWS IMMUNOLOGY (2020)
M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis
Richa Shrivastava et al.
CYTOKINE (2019)
mTOR inhibitor INK128 attenuates dextran sodium sulfate-induced colitis by promotion of MDSCs on Treg cell expansion
Guoping Shi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
Seung H. Choi et al.
GENES & DEVELOPMENT (2019)
mTOR Signaling pathway as a master regulator of memory CD8+ T-cells, Th17, and NK cells development and their functional properties
Davood Rostamzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy
Helen Carrasco Hope et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Chao Zhang et al.
NATURE COMMUNICATIONS (2019)
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Cedric Magaway et al.
CELLS (2019)
Immune targets in the tumor microenvironment treated by radiotherapy
Omer M. Ozpiskin et al.
THERANOSTICS (2019)
Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis
Karl Katholnig et al.
JCI INSIGHT (2019)
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
Laurel B. Darragh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunometabolism and natural killer cell responses
Katie L. O'Brien et al.
NATURE REVIEWS IMMUNOLOGY (2019)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival
Thomas A. Werfel et al.
CANCER RESEARCH (2018)
TORching a semaphore for alternative macrophage activation
Jayne Louise Wilson et al.
NATURE IMMUNOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Metabolic Modulation in Macrophage effector Function
Ciana Diskin et al.
FRONTIERS IN IMMUNOLOGY (2018)
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells
Marcella Manerba et al.
PLOS ONE (2018)
Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice
Min-Jung Park et al.
SCIENTIFIC REPORTS (2018)
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Marc O. Johnson et al.
CELL (2018)
Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression
Christopher M. Rice et al.
NATURE COMMUNICATIONS (2018)
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Ramon I. Klein Geltink et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses
Angelika Riedl et al.
JOURNAL OF CELL SCIENCE (2017)
MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
Russell G. Jones et al.
IMMUNITY (2017)
Cutting Edge: Defective Aerobic Glycolysis Defines the Distinct Effector Function in Antigen-Activated CD8+ Recent Thymic Emigrants
Cody A. Cunningham et al.
JOURNAL OF IMMUNOLOGY (2017)
Granulocytes as modulators of dendritic cell function
Annelot Breedveld et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT
Yuchao Gu et al.
MOLECULAR CELL (2017)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June et al.
NATURE MEDICINE (2017)
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity
Seraina Faes et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells
Giuliana P. Mognol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
Aibin Zhang et al.
CANCER MEDICINE (2017)
Mighty RapaLink-1 vanquishes undruggable mutant mTOR in glioblastoma
Meena Jhanwar-Uniyal
TRANSLATIONAL CANCER RESEARCH (2017)
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Yakir Guri et al.
CANCER CELL (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
Control of B lymphocyte development and functions by the mTOR signaling pathways
Terri N. Iwata et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Alessia Angelin et al.
CELL METABOLISM (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression
Monika Linke et al.
NATURE IMMUNOLOGY (2017)
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
Kristin J. Lastwika et al.
CANCER RESEARCH (2016)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Yangzom D. Bhutia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Targeting mTOR for the treatment of B cell malignancies
Jong-Hoon Scott Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Irradiation and Immunotherapy: From Concept to the Clinic
April K. S. Salama et al.
CANCER (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
Meghan Morrison Joly et al.
CANCER RESEARCH (2016)
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Mathias Wenes et al.
CELL METABOLISM (2016)
Structural insights of mTOR complex 1
Hai-Xin Yuan et al.
CELL RESEARCH (2016)
Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation
Stanley Ching-Cheng Huang et al.
IMMUNITY (2016)
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Kelly L. Singel et al.
IMMUNOLOGICAL REVIEWS (2016)
Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia
Peter J. Siska et al.
JOURNAL OF IMMUNOLOGY (2016)
TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis
Fiamma Salerno et al.
JOURNAL OF IMMUNOLOGY (2016)
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system
Sung Hoon Cho et al.
NATURE (2016)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
Cancer anabolic metabolism inhibitors move into clinic
Ken Garber
NATURE BIOTECHNOLOGY (2016)
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
Thomas Welte et al.
NATURE CELL BIOLOGY (2016)
Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis
Jun Weil et al.
NATURE IMMUNOLOGY (2016)
Immunometabolism of regulatory T cells
Ryan Newton et al.
NATURE IMMUNOLOGY (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner
Lianjun Zhang et al.
CELL REPORTS (2016)
Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation
Anthony J. Covarrubias et al.
ELIFE (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Neutrophils in cancer: neutral no more
Seth B. Coffelt et al.
NATURE REVIEWS CANCER (2016)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1
Wilhelm Palm et al.
CELL (2015)
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions
Kathrin Renner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
Kristen N. Pollizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus
Lorenzo Gallon et al.
KIDNEY INTERNATIONAL (2015)
The S6K protein family in health and disease
Mariana R. Tavares et al.
LIFE SCIENCES (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella et al.
NATURE GENETICS (2015)
TSC1 Promotes B Cell Maturation but Is Dispensable for Germinal Center Formation
Xinxin Ci et al.
PLOS ONE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal-/- mice
T. Zhao et al.
ONCOGENE (2015)
Regulation of innate immune cell function by mTOR
Thomas Weichhart et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
Tania Valencia et al.
CANCER CELL (2014)
The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
Matthew M. Staron et al.
IMMUNITY (2014)
Autophagy in inflammation, infection, neurodegeneration and cancer
Daniela S. Arroyo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Mechanistic Target of Rapamycin Inhibition Extends Cellular Lifespan in Dendritic Cells by Preserving Mitochondrial Function
Eyal Amiel et al.
JOURNAL OF IMMUNOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Stanley Ching-Cheng Huang et al.
NATURE IMMUNOLOGY (2014)
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
Nikhil Wagle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Control of glutamine metabolism by the tumor suppressor Rb
M. R. Reynolds et al.
ONCOGENE (2014)
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Andrea Schietinger et al.
TRENDS IN IMMUNOLOGY (2014)
Myeloid-derived Suppressor Cells in the Inflammatory Bowel Diseases
Dmitry V. Ostanin et al.
INFLAMMATORY BOWEL DISEASES (2013)
Treg and CTLA-4: Two intertwining pathways to immune tolerance
Lucy S. K. Walker
JOURNAL OF AUTOIMMUNITY (2013)
Where is mTOR and what is it doing there?
Charles Betz et al.
JOURNAL OF CELL BIOLOGY (2013)
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Chen Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor α
Katarzyna Wejksza et al.
JOURNAL OF IMMUNOLOGY (2013)
Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2013)
mTORC1 couples immune signals and metabolic programming to establish Treg-cell function
Hu Zeng et al.
NATURE (2013)
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Patrick M. Gubser et al.
NATURE IMMUNOLOGY (2013)
The TSC-mTOR pathway regulates macrophage polarization
Vanessa Byles et al.
NATURE COMMUNICATIONS (2013)
Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells
Bart Everts et al.
BLOOD (2012)
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells
David K. Finlay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cutting Edge: mTORC1 in Intestinal CD11c+CD11b+ Dendritic Cells Regulates Intestinal Homeostasis by Promoting IL-10 Production
Masashi Ohtani et al.
JOURNAL OF IMMUNOLOGY (2012)
Regulating Mammalian Target of Rapamycin To Tune Vaccination-Induced CD8+ T Cell Responses for Tumor Immunity
Qingsheng Li et al.
JOURNAL OF IMMUNOLOGY (2012)
Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
Eyal Amiel et al.
JOURNAL OF IMMUNOLOGY (2012)
Glutaminolysis Activates Rag-mTORC1 Signaling
Raul V. Duran et al.
MOLECULAR CELL (2012)
Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation
Camila Macedo et al.
TRANSPLANTATION RESEARCH (2012)
Regulation of the SREBP transcription factors by mTORC1
Caroline A. Lewis et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells
Leona Gabrysova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Ruoning Wang et al.
IMMUNITY (2011)
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
Lucia Lisi et al.
JOURNAL OF NEUROINFLAMMATION (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Jonathan D. Powell et al.
IMMUNITY (2010)
Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways
Keunwook Lee et al.
IMMUNITY (2010)
The role of mTOR in memory CD8+T-cell differentiation
Koichi Araki et al.
IMMUNOLOGICAL REVIEWS (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Shijie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery
Shaobo Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Olivier Joffre et al.
IMMUNOLOGICAL REVIEWS (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Stephen P. Cobbold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The multiple facets of mTOR in immunity
Thomas Weichhart et al.
TRENDS IN IMMUNOLOGY (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production
Robert Tripmacher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals
Susan Moir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Hypoxia and hypoxia-inducible factor-1α modulate lipopolysaccharide-induced dendritic cell activation and function
Jonathan Jantsch et al.
JOURNAL OF IMMUNOLOGY (2008)
De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR
Johnthomas Kang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
Linda V. Sinclair et al.
NATURE IMMUNOLOGY (2008)
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function
Lu-En Wai et al.
TRANSPLANTATION (2008)
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
Janine Masri et al.
CANCER RESEARCH (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Cunren Liu et al.
BLOOD (2007)
Use of sirolimus in solid organ transplantation
Joshua J. Augustine et al.
DRUGS (2007)
Humoral immunity, inflammation and cancer
Ting-Ting Tan et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
Phosphoinositide 3-kinase: Diverse roles in immune cell activation
JA Deane et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
JD Horton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Share Paper
